Cargando…

Doppler myocardial performance index combined with plasma B-type natriuretic peptide levels as a marker of cardiac function in patients with decompensated cirrhosis

BACKGROUND: In chronic liver diseases, cirrhosis ranks as the 14th highest death cause worldwide, developing into decompensated cirrhosis. A potential and feasible technique in assessing cardiac function is urgent. This study explores if the Doppler myocardial performance (Tei) index combined with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Li-Kun, An, Xiao-Fei, Wu, Xue-Liang, Zhang, Su-Mei, Yang, Rui-Min, Han, Chao, Yang, Jie-Lin, Wang, Yi-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283142/ https://www.ncbi.nlm.nih.gov/pubmed/30508917 http://dx.doi.org/10.1097/MD.0000000000013302

Ejemplares similares

Correlation of Serum Cardiac Markers with Acute Decompensating Events in Liver Cirrhosis
por: Li, Miaomiao, et al.
Publicado: (2020)

Brain Natriuretic Peptide in Liver Cirrhosis and Fatty Liver: Correlation with Cardiac Performance
por: Metwaly, Amna, et al.
Publicado: (2016)

Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
por: Takashio, Seiji, et al.
Publicado: (2019)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Metabonomics Analysis of Myocardial Metabolic Dysfunction in Patients with Cardiac Natriuretic Peptide Resistance
por: Chang, Pan, et al.
Publicado: (2020)

Evaluation of cardiac functions of cirrhotic children using serum brain natriuretic peptide and tissue Doppler imaging
por: Fattouh, Aya M, et al.
Publicado: (2016)

Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis
por: McPhail, Mark J.W., et al.
Publicado: (2016)

Plasma brain natriuretic peptide as a surrogate marker for cardioembolic stroke
por: Yukiiri, Kazushi, et al.
Publicado: (2008)

Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
por: McLean, AS, et al.
Publicado: (2003)

Correlation between B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide in patients presenting to an emergency department with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2005)

Value of natriuretic peptides and tissue Doppler imaging in the estimation of left ventricular filling pressure in patients with cardiac amyloidosis
por: Brun, Stéphanie, et al.
Publicado: (2019)

Compression from an enlarged spleen in decompensated cirrhosis mimicking the appearance of fundal varices
por: Lin, Xue-Mei, et al.
Publicado: (2023)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Prognostic nutritional index: A potential biomarker for predicting the prognosis of decompensated liver cirrhosis
por: Xie, Yanan, et al.
Publicado: (2023)

Admissional B-type natriuretic peptide is an independent predictor of outcome in patients with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2003)

Clinical significance of plasma levels of brain natriuretic peptide and cardiac troponin T in patients with sepsis
por: WANG, JIFENG, et al.
Publicado: (2016)

Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in decompensated chronic heart failure patients treated with levosimendan
por: Ferri, MB, et al.
Publicado: (2006)

Drotrecogin alfa (activated) reduces the plasma levels of N-terminal prohormone atrial natriuretic peptide and N-terminal prohormone brain natriuretic peptide as markers of cardiac depression in septic patients
por: Hoffmann, U, et al.
Publicado: (2004)

The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population
por: Chen, Li Juen, et al.
Publicado: (2016)

Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective
por: Dahdah, Nagib, et al.
Publicado: (2013)

Myocardial Fibrosis and Cardiac Decompensation in Aortic Stenosis
por: Chin, Calvin W.L., et al.
Publicado: (2017)

Role of Brain Natriuretic Peptide as a Prognostic Marker in Non-Cardiac Surgery
por: Jeon, Doo Soo
Publicado: (2011)

In-hospital brain natriuretic peptide and N-terminal prohormone brain natriuretic peptide variations are predictors of short-term and long-term outcome in acute decompensated heart failure
por: Di Somma, Salvatore, et al.
Publicado: (2011)

Left ventricular dysfunction by conventional and tissue Doppler echocardiography in pediatric hemodialysis patients: relation with plasma brain natriuretic peptide levels
por: Mostafa, Fatma A., et al.
Publicado: (2018)

Assessing prognosis of pulmonary embolism using tissue-Doppler echocardiography and brain natriuretic peptide
por: Rodrigues, Ana Clara Tude, et al.
Publicado: (2013)

Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis
por: Pose, Elisa, et al.
Publicado: (2021)

Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis
por: Riva, Antonio, et al.
Publicado: (2020)

Diagnostic and prognostic significance of cell death markers in patients with cirrhosis and acute decompensation
por: Stoffers, Philipp, et al.
Publicado: (2022)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Myocardial tissue Doppler echocardiography and N-terminal B-type natriuretic peptide (NT-proBNP) in diastolic and systolic heart failure
por: Knebel, Fabian, et al.
Publicado: (2008)

Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis
por: Lee, Soon Kyu, et al.
Publicado: (2018)

Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity
por: Kistorp, Caroline, et al.
Publicado: (2014)

Natriuretic Peptides as a Prognostic Marker for Delirium in Cardiac Surgery—A Pilot Study
por: Saller, Thomas, et al.
Publicado: (2020)

Serum Cardiac Markers in Patients with Acute Myocardial Infarction: Oxidative Stress, C-Reactive Protein and N-Terminal Probrain Natriuretic Peptide
por: Kasap, Seçil, et al.
Publicado: (2007)

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk
por: Sarzani, Riccardo, et al.
Publicado: (2017)

The role of B-type natriuretic peptide in diagnosing acute decompensated heart failure in chronic kidney disease patients
por: Kadri, Amer N., et al.
Publicado: (2018)

Accuracy of B-natriuretic peptide for the diagnosis of decompensated heart failure in muscular dystrophies patients with chronic respiratory failure
por: Meng, Paris, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_up8raiajgd8ormu55vkkch35gs